Scientific Award Foundation AstraZeneca - Cardiovascular/Metabolic Diseases 2016


The Foundation AstraZeneca attaches great importance to promoting research into cardiovascular/metabolic diseases. On the initiative of the Foundation AstraZeneca, the FWO and F.R.S.-FNRS will in 2016 award a scientific prize in recognition of innovative research in this area.


  • Prize amounting to 25,000 EURO.
  • Rewards basic, clinical or epidemiological research in cardiovascular/metabolic medicine with a focus on cardio-metabolic risk factors and their role in the prevention of cardiomyopathic/atherothrombotic diseases.
  • The prize is intended to reward established investigators on the basis of his/her previous work, with a perspective of future development in the same field.

Profile and conditions

  • You have a PhD.
  • The applicant cannot have reached the age of 45 on the date of submission deadline.
  • The prize can only be given to an individual scientist from postdoctoral level onwards. The applicant’s research activities have been carried out in Belgium in a biomedical context for at least five years prior to the submission deadline.


  • Submit your candidacy using the appropriate form, filled in correctly and completely (in English), before September 1, 2016.
  • Your candidacy is submitted to a jury.
  • The jury selects the laureate.
  • The Board of Trustees decides on the allocation.

Regulations and downloads